Intelesens Limited

Intelesens (formerly Sensor Technology & Devices Limited or ST&D) was incorporated in August 2000 with Enterprise Equity leading an investment of £1.7m into the company in May 2005.

The company, a University of Ulster spin-out, has developed a range of innovative sensor and electrode components for medical devices.

Intelesens currently has OEM relationships with a number of medical device manufacturers. From V-Patch, a wireless vital signs system that will monitor ECG, temperature and respiration rate continuously, to an in-home foetal monitoring patch that could help expectant mothers predict the onset of their own labour, the OEM products are primarily geared towards the monitoring of human vital signs such as blood pressure and the physiological measurement of muscular or vascular activity.

In addition to products that have been developed specifically for medical device partners, Intelesens have developed their own range of patented products, for example, ‘Electronic Nose’, which unlike previous competitor attempts is uniquely able to measure any number of gas emissions from a variety of sources including the human breath. This gives a high degree of sensitivity to a full spectrum of components, which can be used to screen for a range of medical conditions from asthma and diabetes to certain types of cancer. The potential applications for the ‘electronic nose’ are however vast ranging from the brewing and wine making industries to catering and health & safety control.

Chief Executive Officer: Michael Caulfield
Enterprise Equity Contact: Aidan Langan

<< BACK